Results 21 to 30 of about 53,162 (283)

Evaluation of CLIA plus NAT for detecting HBsAg single-ELISA-reactive samples of blood donors

open access: yesZhongguo shuxue zazhi, 2022
Objective To study the detection performance of HBsAg single-ELISA-reactive samples of blood donors. Methods Two kinds of ELISA reagents from different manufacturers (named as reagents A and B) were used for HBsAg screening.
Jiayi SUN   +7 more
doaj   +1 more source

Using the quantitative determination of HBsAg to predict the course of chronic hepatitis B in women during pregnancy and after childbirth

open access: yesЖурнал инфектологии, 2014
This study is based on the investigation of 31 HB V-infected women, which have observed at Botkin Infectious Hospital in 2012. Considerable variations of viral load in the course of pregnancy have been observed in the HB V cohort.
M. A. Belopolskaya   +3 more
doaj   +1 more source

Genotypes and Subtypes of Hepatitis B Virus Isolates in the Territory of Siberia

open access: yesПроблемы особо опасных инфекций, 2011
Identified are the occurrence, serotypic and genotypic variations of Hepatitis B virus isolates (HBV) among the Novosibirsk region inhabitants (n=2000), native population of the Alarsk District of the Irkutsk Region (n=487) and Shuryshkarsk Township of ...
G. V. Kochneva   +7 more
doaj   +1 more source

State‐of‐the‐Art, Insights, and Perspectives for MOFs‐Nanocomposites and MOF‐Derived (Nano)Materials

open access: yesAdvanced Materials, EarlyView.
Different approaches to MOF‐NP composite formation, such as ship‐in‐a‐bottle, bottle‐around‐the‐ship and in situ one‐step synthesis, are used. Owing to synergistic effects, the advantageous features of the components of the composites are beneficially combined, and their individual drawbacks are mitigated.
Stefanos Mourdikoudis   +6 more
wiley   +1 more source

HBsAg sT123N mutation induces stronger antibody responses to HBsAg and HBcAg and accelerates in vivo HBsAg clearance

open access: yesVirus Research, 2015
Immune escape mutants with mutations in the hepatitis B surface antigen (HBsAg) major hydrophilic region (MHR) often emerge in association with diagnostic failure or breakthrough of HBV infection in patients with anti-HBs antibodies. Some mutants harboring substitutions to Asn in HBsAg MHR may have an additional potential N-glycosylation site.
Li, Songxia   +11 more
openaire   +2 more sources

Implantable Microarray Patch: Engineering at the Nano and Macro Scale for Sustained Therapeutic Release via Synthetic Biodegradable Polymers

open access: yesAdvanced Materials Technologies, Volume 10, Issue 6, March 18, 2025.
This review focuses on the application of synthetic biodegradable microarray patches (MAPs) in sustained drug delivery. Compared to conventional MAPs which release drugs into the skin in an immediate manner, these implantable MAPs release drugs into skin microcirculation gradually as the biodegradable polymers degrade, thus offering sustained release ...
Li Zhao   +6 more
wiley   +1 more source

prevalence of hepatitis B among thalassemic patients in Kerman [PDF]

open access: yesJournal of Kerman University of Medical Sciences, 1997
A prospective case control study was carried out to evaluate the prevalence of HBsAg in 129 thalassemic patients and 113 children as a control group.ELISA was used for serologic investigations.
A.A Vahidi, A Ahmadi, Y Nikiyan
doaj  

RELA Ablation Contributes to Progression of Hepatocellular Carcinoma with TP53R249S Mutation and is a Potential Therapeutic Target

open access: yesAdvanced Science, EarlyView.
Genome‐wide CRISPR/Cas9 based screening identified RELA as a key tumor suppressor in TP53R249S‐mutant HCC. Its loss promotes tumorigenesis and metastasis via DVL1‐mediated Wnt/β‐catenin activation, while its agonist betulinic acid suppresses tumor progression.
Zhiping Wu   +17 more
wiley   +1 more source

Prevalence of HBe Ag and LFT Survey in HBsAg Positive Blood Donors in Kerman [PDF]

open access: yesJournal of Kerman University of Medical Sciences, 2003
The hepatitis-B virus (HBV) is one of the most common chronic pathogens in the world. More than 2 billions of world population have been exposed to this virus and 350 millions of them (5% of world population) are chronic carriers of HBV.
M.J Zahedi   +4 more
doaj  

Elevation of BSF-2 Level in Serum of Patients with Hepatitis B Virus

open access: yesМедицинская иммунология, 2021
Background: Hepatitis B is the main infection of the injured liver for humans. Inflammation of the liver is caused by hepatitis viruses may lead to cirrhosis and hepatocellular carcinoma.
Ali A. Dawood   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy